{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:16:03Z","timestamp":1793394963825,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":508,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"FINEP Research Grant \u201cRede Instituto Brasileiro de Neuroci\u00eancia (IBN-Net)\u201d","award":["01.06.0842-00"],"award-info":[{"award-number":["01.06.0842-00"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)"},{"name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Estado de Santa Catarina","award":["1346\/2010-3"],"award-info":[{"award-number":["1346\/2010-3"]}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.brainresbull.2012.01.003","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T15:07:53Z","timestamp":1326294473000},"page":"397-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro"],"prefix":"10.1016","volume":"87","author":[{"given":"Dirleise","family":"Colle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana M.","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix A.","family":"Antunes Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.brainresbull.2012.01.003_bib0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1212\/WNL.42.4.733","article-title":"Alternative excitotoxic hypotheses","volume":"42","author":"Albin","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0010","first-page":"637","article-title":"Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity","volume":"13","author":"Ali","year":"1992","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainresbull.2007.12.008","article-title":"An organotellurium compound with antioxidant activity against excitotoxic agents without neurotoxic effects in brain of rats","volume":"76","author":"Avila","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-2236(93)90117-5","article-title":"Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases","volume":"16","author":"Beal","year":"1993","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00001756-199502000-00034","article-title":"3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons","volume":"6","author":"Behrens","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0035","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0040","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.e05-07-0607","article-title":"Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin","volume":"17","author":"Benchoua","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington's disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0050","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","article-title":"Oxidative damage in Huntington's disease pathogenesis","volume":"8","author":"Browne","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0055","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/00003495-198937060-00002","article-title":"Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia","volume":"37","author":"Buckley","year":"1989","journal-title":"Drugs"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0060","first-page":"135","article-title":"Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease","volume":"34","author":"Chen","year":"2011","journal-title":"Chang Gung Med. J."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0065","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1523\/JNEUROSCI.10-08-02493.1990","article-title":"Cerebral hypoxia: some new approaches and unanswered questions","volume":"10","author":"Choi","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.expneurol.2008.03.023","article-title":"Mild mitochondrial inhibition in vivo enhances glutamate-induced neuronal damage through calpain but not caspase activation: role of ionotropic glutamate receptors","volume":"212","author":"Del R\u00edo","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0075","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.neuroscience.2007.03.024","article-title":"Exacebation of excitotoxic neuronal death induced during mitochondrial inhibition in vivo: relation to energy imbalance or ATP depletion?","volume":"146","author":"Del R\u00edo","year":"2007","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.brainresbull.2012.01.003_bib0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00702-009-0299-5","article-title":"Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine","volume":"117","author":"Elinos-Calder\u00f3n","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0085","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0161-5890(01)00108-0","article-title":"Calcium and oxidative stress: from cell signaling to cell death","volume":"38","author":"Ermak","year":"2001","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.brainresbull.2012.01.003_bib0090","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/toxsci\/kfp219","article-title":"Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells","volume":"112","author":"Farina","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/exnr.1996.0068","article-title":"Energy and glutamate dependency of 3-nitropropionic acid neurotoxicity in culture","volume":"138","author":"Fink","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0100","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.nbd.2009.02.014","article-title":"Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease","volume":"34","author":"Giamp\u00e0","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0306-4522(97)00389-8","article-title":"3-Nitropropionic acid exacerbates N-methyl-d-aspartate toxicity in striatal culture by multiple mechanisms","volume":"84","author":"Greene","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.brainresbull.2012.01.003_bib0115","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1074\/jbc.M511270200","article-title":"3-Nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme","volume":"281","author":"Huang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0120","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1096\/fj.05-5085fje","article-title":"Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation","volume":"20","author":"Jacquard","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2009.12.012","article-title":"Neuroprotective effects of (\u2212)-epigallocatechin-3-gallate against quinolinic acid-induced excitotoxicity via PI3K pathway and NO inhibition","volume":"1313","author":"Jang","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0130","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.lfs.2011.02.020","article-title":"Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats","volume":"88","author":"Kalonia","year":"2011","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.brainresbull.2012.01.003_bib0135","first-page":"880","article-title":"Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats","volume":"47","author":"Kalonia","year":"2009","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuro.2009.12.008","article-title":"Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats","volume":"31","author":"Kalonia","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainres.2010.11.060","article-title":"Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats","volume":"1372","author":"Kalonia","year":"2011","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.brainresbull.2012.01.003_bib0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuint.2005.09.002","article-title":"Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease","volume":"48","author":"Kasparov\u00e1","year":"2005","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.brainresbull.2012.01.003_bib0155","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pnpbp.2008.10.013","article-title":"Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunction in rat brain","volume":"33","author":"Kumar","year":"2009","journal-title":"Prog. Neuropsycopharmacol. Prog. Neuropsychopharmacol. Biol. Psych."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1472-8206.2007.00485.x","article-title":"Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms","volume":"21","author":"Kumar","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1734-1140(10)70238-3","article-title":"Huntington's disease: pathogenesis to animal models","volume":"62","author":"Kumar","year":"2010","journal-title":"Pharmacol. Rep."},{"issue":"2b","key":"10.1016\/j.brainresbull.2012.01.003_bib0170","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","article-title":"Role of LOX\/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofenole","volume":"162","author":"Kumar","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pneurobio.2004.02.002","article-title":"Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease","volume":"72","author":"Lee","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0180","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0306-4522(02)00097-0","article-title":"The mechanisms of neuronal death produced by mitochondrial toxin 3-nitropropionic acid: the roles of N-methyl-d-aspartate glutamate receptors and mitochondrial calcium overload","volume":"112","author":"Lee","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nbd.2010.11.018","article-title":"Proteasomal dysfunction in aging and Huntington disease","volume":"43","author":"Li","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0190","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/cdd.2009.22","article-title":"Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway","volume":"16","author":"Liot","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.brainresbull.2012.01.003_bib0200","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0306-4522(01)00323-2","article-title":"Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates","volume":"106","author":"Massieu","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0205","first-page":"8","article-title":"Intracellular calcium overload in a model of quinolinic acid neurotoxicity in organotypic culture of rat hippocampus; inhibited by nimodipine","volume":"35","author":"Matyja","year":"1997","journal-title":"Folia Neuropathol."},{"issue":"2","key":"10.1016\/j.brainresbull.2012.01.003_bib0210","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI45691","article-title":"Energy deficit in Huntington disease: why it matters","volume":"121","author":"Mochel","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0215","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11064-007-9402-1","article-title":"Glutamate-induced toxicity in hippocampal slices involves apoptotic features and p38MAPK signaling","volume":"33","author":"Molz","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2004.02.004","article-title":"Effect of glucocorticoids on 3-nitropropionic acid-induced oxidative stressing synaptosomes","volume":"488","author":"Montilla","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.brainresbull.2012.01.003_bib0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0230","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","article-title":"Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced","volume":"451","author":"Novelli","year":"1988","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.brainresbull.2012.01.003_bib0235","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/A:1020724102773","article-title":"Neuroprotective effect of GMP in hippocampal slices submitted to an in vitro model of ischemia","volume":"22","author":"Oliveira","year":"2002","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0240","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1523\/JNEUROSCI.17-09-03064.1997","article-title":"Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis","volume":"7","author":"Pang","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0245","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2007.04.051","article-title":"Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats","volume":"1157","author":"Park","year":"2007","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.brainresbull.2012.01.003_bib0250","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s11064-008-9861-z","article-title":"Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus","volume":"34","author":"Pereira","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0255","doi-asserted-by":"crossref","first-page":"513","DOI":"10.33549\/physiolres.931049","article-title":"Integrative hypothesis for Huntington's Disease: a brief review of experimental evidence","volume":"56","author":"P\u00e9rez-De La Cruz","year":"2007","journal-title":"Physiol. Res."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0260","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1460-9568.2008.06088.x","article-title":"Cytoplasmic calcium mediates oxidative damage in an excitotoxic\/energetic deficit synergic model in rats","volume":"27","author":"P\u00e9rez-De La Cruz","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0265","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neuint.2010.03.008","article-title":"Time-course correlation of early toxic events in three models of striatal damage: modulation by proteases inhibition","volume":"56","author":"P\u00e9rez-De La Cruz","year":"2010","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.brainresbull.2012.01.003_bib0270","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11064-005-2617-0","article-title":"N-methyl-d-aspartate receptors are involved in the quinolinic acid, but not in the malonate pro-oxidative activity in vitro","volume":"30","author":"Puntel","year":"2005","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.brainresbull.2012.01.003_bib0275","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","article-title":"Animal models of Huntington's disease","volume":"48","author":"Ramaswamy","year":"2007","journal-title":"ILAR J."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0280","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jnr.22574","article-title":"3\u03b3-Aminobutyric acid type B receptor changes in the rat striatum and substantia nigra following intrastriatal quinolinic acid lesions","volume":"89","author":"Rekik","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0285","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00966592","article-title":"Quinolinic acid is a potent lipid peroxidant in rat brain homogenates","volume":"16","author":"R\u00edos","year":"1991","journal-title":"Neurochem. Res."},{"issue":"40","key":"10.1016\/j.brainresbull.2012.01.003_bib0290","first-page":"1","article-title":"Huntington's disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0295","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0300","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbr.2010.11.006","article-title":"Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes","volume":"217","author":"Rossignol","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0305","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00001756-200103260-00049","article-title":"Quinolinic acid induces oxidative stress in rat brain synaptosomes","volume":"12","author":"Santamar\u00eda","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0310","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neures.2006.10.013","article-title":"In vitro effect of quinolinic acid on energy metabolism in brain of young rats","volume":"57","author":"Schuck","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0315","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0320","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1471-4159.2007.05174.x","article-title":"Excitotoxic damage, disrupted energy metabolism and oxidative stress in the rat brain: antioxidant and neuroprotective effects of l-carnitine","volume":"105","author":"Silva-Adaya","year":"2008","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.brainresbull.2012.01.003_bib0325","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1073858410386236","article-title":"Gene therapy in mouse models of Huntington disease","volume":"17","author":"Southwell","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0330","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainresbull.2012.01.003_bib0335","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s007260070059","article-title":"Possible mediation of quinolinic acid-induced hippocampal damage by reactive oxygen species","volume":"19","author":"Stone","year":"2000","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.brainresbull.2012.01.003_bib0340","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000243650","article-title":"Protective effect of tert-butylhydroquinone on the quinolinic-acid-induced toxicity in rat striatal slices: role of the Nrf2-antioxidant response element pathway","volume":"18","author":"Tasset","year":"2010","journal-title":"Neurosignals"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0345","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","article-title":"Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes","volume":"40","author":"Tavares","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0350","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","article-title":"3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future","volume":"15","author":"T\u00fanez","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0355","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2009.02.326","article-title":"The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection","volume":"283","author":"Vamos","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0360","first-page":"1","article-title":"Selective neuronal vulnerability to oxidative stress in the brain","volume":"2","author":"Wang","year":"2010","journal-title":"Front. Aging Neurosci."},{"issue":"16","key":"10.1016\/j.brainresbull.2012.01.003_bib0365","doi-asserted-by":"crossref","first-page":"15612","DOI":"10.1074\/jbc.M414256200","article-title":"Probucol protects against hypochlorite-induced endothelial dysfunction: indentification of a novel pathway of probucol oxidation to a biologically active intermediate","volume":"280","author":"Witting","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0370","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2009.04.002","article-title":"Where are we with probucol: a new life for an old drug?","volume":"207","author":"Yamashita","year":"2009","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.brainresbull.2012.01.003_bib0375","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5551\/jat.E610","article-title":"Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan","volume":"15","author":"Yamashita","year":"2008","journal-title":"J. Atheroscler. Thromb."},{"issue":"5","key":"10.1016\/j.brainresbull.2012.01.003_bib0380","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","article-title":"Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases","volume":"109","author":"Yang","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2012.01.003_bib0385","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00702-009-0263-4","article-title":"Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies","volume":"116","author":"Zad\u00f3ri","year":"2009","journal-title":"J. Neural. Transm."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923012000044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923012000044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:14:38Z","timestamp":1759781678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923012000044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":77,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0361923012000044"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2012.01.003","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2012.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}